Regional/Distant Stage Lung Cancer Incidence by Year, Black Individuals, New York State Excl New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI
1976 134 37.0 30.7-44.1 104 65.1 52.5-79.7 30 14.7 9.7-21.2
1977 182 51.9 44.2-60.5 140 92.3 76.2-110.7 42 21.3 15.0-29.2
1978 148 40.6 34.0-48.0 117 75.3 60.9-91.8 31 14.9 10.0-21.3
1979 178 47.1 40.0-54.9 130 84.0 68.5-101.7 48 21.1 15.5-28.0
1980 220 55.3 47.9-63.4 159 93.8 78.6-110.9 61 26.9 20.4-34.7
1981 212 52.0 44.9-59.8 162 94.4 79.2-111.5 50 21.1 15.5-27.9
1982 220 53.1 46.0-60.9 170 97.5 82.2-114.7 50 20.9 15.4-27.6
1983 214 49.7 43.0-57.0 161 89.8 75.5-105.8 53 20.8 15.5-27.3
1984 230 53.7 46.7-61.4 165 87.9 74.1-103.4 65 27.9 21.3-35.8
1985 230 50.3 43.8-57.5 166 84.8 71.7-99.6 64 24.7 18.9-31.6
1986 227 50.6 44.0-57.9 167 90.4 76.0-106.5 60 22.9 17.4-29.6
1987 204 42.1 36.4-48.5 150 71.4 59.8-84.4 54 20.0 14.9-26.2
1988 230 47.9 41.7-54.7 160 79.6 66.9-93.9 70 25.5 19.8-32.3
1989 271 54.0 47.5-61.0 189 89.8 76.5-104.7 82 28.7 22.8-35.7
1990 238 48.7 42.5-55.6 169 85.8 72.0-101.1 69 24.1 18.7-30.6
1991 255 50.8 44.5-57.6 167 80.7 67.7-95.1 88 30.3 24.2-37.4
1992 250 46.4 40.7-52.8 170 77.7 65.4-91.6 80 25.4 20.1-31.7
1993 217 39.6 34.3-45.4 145 64.0 53.2-76.2 72 22.8 17.7-28.7
1994 262 45.6 40.1-51.6 152 63.8 53.3-75.5 110 33.2 27.2-40.1
1995 256 44.6 39.1-50.6 158 64.5 54.1-76.1 98 30.2 24.4-36.9
1996 294 49.2 43.6-55.3 178 72.5 61.4-84.9 116 33.8 27.8-40.5
1997 299 49.8 44.1-55.9 193 78.1 66.6-90.8 106 30.5 24.9-37.0
1998 305 49.0 43.5-55.0 182 69.9 59.3-81.7 123 34.6 28.7-41.3
1999 281 45.1 39.9-50.9 165 62.8 52.9-73.9 116 32.8 27.0-39.4
2000 310 46.7 41.5-52.3 200 70.6 60.5-81.9 110 29.6 24.2-35.7
2001 319 47.3 42.1-52.9 189 67.9 57.8-79.0 130 33.5 27.9-39.8
2002 298 43.8 38.8-49.2 172 60.8 51.5-71.3 126 32.2 26.7-38.3
2003 344 47.6 42.6-53.1 196 64.6 55.3-75.0 148 35.9 30.3-42.3
2004 376 50.0 44.9-55.5 228 71.3 61.7-81.8 148 34.6 29.2-40.8
2005 390 52.7 47.4-58.4 230 76.1 65.7-87.6 160 37.7 32.0-44.1
2006 359 48.2 43.2-53.6 209 67.3 57.8-77.7 150 35.5 30.0-41.7
2007 378 48.2 43.3-53.4 219 66.8 57.7-76.9 159 35.1 29.8-41.1
2008 385 47.8 43.0-53.0 220 66.1 57.0-76.0 165 35.5 30.2-41.4
2009 415 49.3 44.5-54.4 246 69.8 60.7-79.7 169 35.3 30.1-41.1
2010 440 50.9 46.1-56.0 241 66.1 57.5-75.6 199 40.4 34.9-46.5
2011 414 46.0 41.5-50.8 236 61.6 53.4-70.5 178 35.1 30.0-40.7
2012 465 50.6 45.9-55.5 274 70.3 61.7-79.7 191 36.5 31.4-42.1
2013 437 45.0 40.7-49.6 238 59.2 51.4-67.6 199 35.3 30.5-40.6
2014 433 44.1 39.9-48.6 238 56.4 49.1-64.6 195 34.9 30.1-40.3
2015 476 47.9 43.6-52.5 274 67.8 59.6-76.8 202 34.4 29.8-39.6
2016 454 44.6 40.5-49.0 257 59.8 52.4-68.0 197 33.7 29.1-38.9
2017 411 38.5 34.8-42.6 228 52.3 45.4-59.9 183 29.7 25.5-34.4
2018 407 37.3 33.7-41.3 212 47.1 40.6-54.2 195 30.9 26.6-35.6
2019 419 36.9 33.4-40.7 235 48.7 42.4-55.7 184 28.6 24.6-33.2
2020 380 32.0 28.8-35.5 208 40.5 34.9-46.7 172 26.1 22.3-30.4

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • Regional/distant stage indicates disease has spreaded beyond the limits of the organ of origin at diagnosis.